Monoclonal Antibodies From COVID-19 Convalescent Patients Target Cryptic Epitopes For Broad SARS

Proceedings of the National Academy of Sciences, Volume 123, Issue 13, March 2026. SignificanceThe rapid emergence of SARS-CoV-2 variants that efficiently spread and evade antibody-based treatments underscores the need for countermeasures that remain effective as the virus evolves. In this study, two human mAbs, TAU-1109 and TAU-2310, ...